ClinConnect ClinConnect Logo
Search / Trial NCT05628194

ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES

Launched by UNIVERSITY OF MINNESOTA · Nov 16, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is called "Assessing the Gay Male Experience with Anal Cancer Prevention Strategies." It aims to understand how men who have sex with men (MSM) feel about anal cancer screening and what they know about it. By using a large survey shared on social media, the study wants to learn about their experiences and opinions on care that helps reduce the risk of anal cancer.

To participate in this study, you need to be at least 18 years old, live in the U.S., and have sexual relationships with male partners. You should also be comfortable speaking either English or Spanish. If you join the study, you'll be asked to fill out a survey about your knowledge and experiences related to anal cancer screening. This research is important because it can help improve awareness and healthcare strategies for anal cancer prevention among MSM.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • ≥18 years of age
  • Current resident of the U.S.
  • Engage in anoreceptive intercourse with male partners
  • Fluent in English or Spanish
  • Exclusion Criteria:
  • Under the age of 18 years old
  • Not living in the United States
  • Not born with sex assigned at birth as male
  • Does not engage in sex with male partners

About University Of Minnesota

The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.

Locations

Minneapolis, Minnesota, United States

Minneapolis, Minnesota, United States

Patients applied

0 patients applied

Trial Officials

Elliot Arsoniadis, M.D., Ph.D

Principal Investigator

University of Minnesota

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials